The 2025-26 LDP application period is July 1, 2024 through September 23, 2024.  Applicants will be notified in April 2025.

Participants learn valuable leadership skills, gain exposure to the roles and mission of ASCO, and learn about the Society’s place in developing the future of cancer care. This program is intended to develop future ASCO leaders.

ASCO Practice Central helps oncology professionals navigate a complicated and ever-changing practice environment—while providing high-quality patient care.

Stay updated on the latest oncology has to offer with ASCO Education—your online, on-demand resource for timely information, real-world application, and practice-changing care.

Cancer.Net brings the expertise and resources of ASCO to people living with cancer and those who care for and about them to help patients and families make informed health care decisions.

Conquer Cancer, the ASCO Foundation, raises funds to support the world's leading researchers who are improving treatments and discovering cures for every cancer, every patient, everywhere.

Applicants are encouraged to start their application early due to the complexity of the online application process. To apply, please visit ASCO SurveyMonkey Apply.

Equipped with high-definition video recording, wide-angle lens, and infrared night vision, the SJCAM Police Body Camera captures crucial evidence and details, even in low-light conditions. Its rugged and durable design, coupled with waterproof and shockproof capabilities, guarantees it can withstand the demands of daily police work. Enhanced features such as built-in GPS, one-touch recording, and secure data encryption further ensure the integrity and reliability of captured footage. Empower your officers with the SJCAM Police Body Camera and enhance transparency, accountability, and public trust in law enforcement operations. Together, let’s build safer communities.

The Leadership Development Program Work Group reserves the right to evaluate and determine applicants’ eligibility based on the information and justifications included in the application materials.

Sixteen participants are accepted for the annual program, and they are expected to attend and actively participate in five live meetings:

ASCO’s Targeted Agent and Profiling Utilization Registry (TAPUR) Study is a non-randomized clinical trial aiming to describe the performance of commercially available, targeted anticancer drugs prescribed for treatment of patients with advanced cancer with a potentially actionable genomic variant.

ASCOconnection.org features blogs from members, the online version of the membership magazine, a discussion area, working groups, and links to the Membership Directory, Career Center, and Volunteer Portal.

ASCO’s growing roster of cutting-edge journals serves readers as the most credible, authoritative, peer-reviewed resources for significant clinical oncology research and research that informs the delivery of efficient, high-quality cancer care across the globe.

Note: ASCO will consider extending an eligibility exception for a new child, personal or family illness, or other compelling interruptions in professional development that impacted a candidate’s ability to apply for or participate in the Leadership Development Program.

2318 Mill Road, Suite 800, Alexandria, VA 22314 • 571-483-1300 © 2024 American Society of Clinical Oncology (ASCO). All Rights Reserved Worldwide.

Candidates who wish to request an eligibility extension should submit their rationale in writing to the Leadership Development Program Committee.

This program requires a time commitment for travel and training. ASCO reimburses participants for hotel and travel costs related to attendance at leadership development meetings and activities held at ASCO headquarters; however, the Annual Meeting travel and hotel expenses are not covered.

A cutting-edge health information technology platform, CancerLinQ® enables practitioners to learn from individual patients. By assembling vast amounts of usable, searchable, real-world data, CancerLinQ seeks to improve the quality and value of cancer care.

In law enforcement, reliable and effective tools are vital for ensuring public safety and maintaining community trust. That’s why we proudly present the SJCAM Police Body Camera, a cutting-edge solution designed specifically for law enforcement professionals. This body camera is a game-changer with its robust features and advanced technology.

ASCO Daily News is the official conference reporter for ASCO meetings and symposia, providing high-quality, unbiased research summaries and oncology news to members and oncology health care providers.

The ASCO Post, in partnership with the American Society of Clinical Oncology, communicates news of the highest quality multidisciplinary cancer care to a broad audience of oncology professionals and members.